Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

Tapia MD., Sow SO., Lyke KE., Haidara FC., Diallo F., Doumbia M., Traore A., Coulibaly F., Kodio M., Onwuchekwa U., Sztein MB., Wahid R., Campbell JD., Kieny M-P., Moorthy V., Imoukhuede EB., Rampling T., Roman F., De Ryck I., Bellamy AR., Dally L., Mbaya OT., Ploquin A., Zhou Y., Stanley DA., Bailer R., Koup RA., Roederer M., Ledgerwood J., Hill AVS., Ballou WR., Sullivan N., Graham B., Levine MM.

DOI

10.1016/s1473-3099(15)00362-x

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

01/2016

Volume

16

Pages

31 - 42

Permalink Original publication